Skip to main content
Journal cover image

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.

Publication ,  Journal Article
Khoja, L; Weber, RP; Australian Ovarian Cancer Study Group, ; Webb, PM; Jordan, SJ; Muthukumar, A; Chang-Claude, J; Fortner, RT; Jensen, A ...
Published in: Gynecol Oncol
January 2022

OBJECTIVE: To evaluate the association between hysterectomy and ovarian cancer, and to understand how hormone therapy (HT) use and endometriosis affect this association. METHODS: We conducted a pooled analysis of self-reported data from 11 case-control studies in the Ovarian Cancer Association Consortium (OCAC). Women with (n = 5350) and without ovarian cancer (n = 7544) who never used HT or exclusively used either estrogen-only therapy (ET) or estrogen+progestin therapy (EPT) were included. Risk of invasive epithelial ovarian cancer adjusted for duration of ET and EPT use and stratified on history of endometriosis was determined using odds ratios (ORs) with 95% confidence intervals (CIs). RESULTS: Overall and among women without endometriosis, there was a positive association between ovarian cancer risk and hysterectomy (OR = 1.19, 95% CI 1.09-1.31 and OR = 1.20, 95% CI 1.09-1.32, respectively), but no association upon adjusting for duration of ET and EPT use (OR = 1.04, 95% CI 0.94-1.16 and OR = 1.06, 95% CI 0.95-1.18, respectively). Among women with a history of endometriosis, there was a slight inverse association between hysterectomy and ovarian cancer risk (OR = 0.93, 95% CI 0.69-1.26), but this association became stronger and statistically significant after adjusting for duration of ET and EPT use (OR = 0.69, 95% CI 0.48-0.99). CONCLUSIONS: The hysterectomy-ovarian cancer association is complex and cannot be understood without considering duration of ET and EPT use and history of endometriosis. Failure to take these exposures into account in prior studies casts doubt on their conclusions. Overall, hysterectomy is not risk-reducing for ovarian cancer, however the inverse association among women with endometriosis warrants further investigation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

January 2022

Volume

164

Issue

1

Start / End Page

195 / 201

Location

United States

Related Subject Headings

  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Menopause
  • Hysterectomy
  • Humans
  • Female
  • Estrogen Replacement Therapy
  • Endometriosis
  • Case-Control Studies
  • 3215 Reproductive medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khoja, L., Weber, R. P., Australian Ovarian Cancer Study Group, ., Webb, P. M., Jordan, S. J., Muthukumar, A., … Lee, A. W. (2022). Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecol Oncol, 164(1), 195–201. https://doi.org/10.1016/j.ygyno.2021.10.088
Khoja, Lilah, Rachel Palmieri Weber, Rachel Palmieri Australian Ovarian Cancer Study Group, Penelope M. Webb, Susan J. Jordan, Aruna Muthukumar, Jenny Chang-Claude, et al. “Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.Gynecol Oncol 164, no. 1 (January 2022): 195–201. https://doi.org/10.1016/j.ygyno.2021.10.088.
Khoja L, Weber RP, Australian Ovarian Cancer Study Group, Webb PM, Jordan SJ, Muthukumar A, et al. Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecol Oncol. 2022 Jan;164(1):195–201.
Khoja, Lilah, et al. “Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.Gynecol Oncol, vol. 164, no. 1, Jan. 2022, pp. 195–201. Pubmed, doi:10.1016/j.ygyno.2021.10.088.
Khoja L, Weber RP, Australian Ovarian Cancer Study Group, Webb PM, Jordan SJ, Muthukumar A, Chang-Claude J, Fortner RT, Jensen A, Kjaer SK, Risch H, Doherty JA, Harris HR, Goodman MT, Modugno F, Moysich K, Berchuck A, Schildkraut JM, Cramer D, Terry KL, Anton-Culver H, Ziogas A, Phung MT, Hanley GE, Wu AH, Mukherjee B, McLean K, Cho K, Pike MC, Pearce CL, Lee AW. Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecol Oncol. 2022 Jan;164(1):195–201.
Journal cover image

Published In

Gynecol Oncol

DOI

EISSN

1095-6859

Publication Date

January 2022

Volume

164

Issue

1

Start / End Page

195 / 201

Location

United States

Related Subject Headings

  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Menopause
  • Hysterectomy
  • Humans
  • Female
  • Estrogen Replacement Therapy
  • Endometriosis
  • Case-Control Studies
  • 3215 Reproductive medicine